Compass Therapeutics, Inc. (CMPX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Compass Therapeutics, Inc. (CMPX)
Company Performance

Current Price

as of Oct 16, 2024

$1.98

P/E Ratio

N/A

Market Cap

$272.43M

Description

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Metrics

Overview

  • HQBoston, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerCMPX
  • Price$1.98+3.66%

Trading Information

  • Market Cap$272.43M
  • Float62.37%
  • Average Daily Volume (1m)539,778
  • Average Daily Volume (3m)462,790
  • EPS-$0.36

Company

  • Revenue$0.85M
  • Rev Growth (1yr)N/A
  • Net Income-$13.08M
  • Gross Margin45.18%
  • EBITDA Margin-1,715.18%
  • EBITDA-$14.58M
  • EV-$7.55M
  • EV/Revenue-8.88
  • P/EN/A
  • P/S320.50
  • P/B1.86
Documents